[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69459-69460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28519]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this
is notice that on June 16, 2010, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as an importer of the basic classes of controlled substances listed in
schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
N-Ethylamphetamine (1475)........................ I
N,N-Dimethylamphetamine (1480)................... I
Fenethylline (1503).............................. I
Gamma Hydroxybutyric Acid (2010)................. I
Ibogaine (7260).................................. I
Lysergic acid diethylamide (7315)................ I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine I
(7348).
Marihuana (7360)................................. I
Tetrahydrocannabinols (7370)..................... I
Mescaline (7381)................................. I
3,4,5-Trimethoxyamphetamine (7390)............... I
4-Bromo-2,5-dimethoxyamphetamine (7391).......... I
4-Bromo-2,5-dimethoxyphenethylamine (7392)....... I
4-Methyl-2,5-dimethoxyamphetamine (7395)......... I
2,5-Dimethoxyamphetamine (7396).................. I
3,4-Methylenedioxyamphetamine (7400)............. I
3,4-Methylenedioxy-N-ethylamphetamine (7404)..... I
3,4-Methylenedioxymethamphetamine (7405)......... I
4-Methoxyamphetamine (7411)...................... I
Alpha-methyltryptamine (7432).................... I
Diethyltryptamine (7434)......................... I
Dimethyltryptamine (7435)........................ I
Psilocybin (7437)................................ I
Psilocyn (7438).................................. I
[[Page 69460]]
5-Methoxy-N,N-diisopropyltryptamine (7439)....... I
N-Benzylpiperazine (7493)........................ I
Etorphine (except HCl) (9056).................... I
Heroin (9200).................................... I
Morphine-N-oxide (9307).......................... I
Normorphine (9313)............................... I
Pholcodine (9314)................................ I
Dextromoramide (9613)............................ I
Dipipanone (9622)................................ I
Racemoramide (9645).............................. I
Trimeperidine (9646)............................. I
Tilidine (9750).................................. I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Methylphenidate (1724)........................... II
Amobarbital (2125)............................... II
Pentobarbital (2270)............................. II
Secobarbital (2315).............................. II
Phencyclidine (7471)............................. II
Phenylacetone (8501)............................. II
Cocaine (9041)................................... II
Codeine (9050)................................... II
Dihydrocodeine (9120)............................ II
Oxycodone (9143)................................. II
Hydromorphone (9150)............................. II
Benzoylecgonine (9180)........................... II
Ethylmorphine (9190)............................. II
Meperidine (9230)................................ II
Methadone (9250)................................. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300).................................. II
Oripavine (9330)................................. II
Thebaine (9333).................................. II
Levo-alphacetylmethadol (9648)................... II
Oxymorphone (9652)............................... II
Poppy Straw Concentrate (9670)................... II
Fentanyl (9801)..................................
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw, and coca
leaves. As explained in the Correction to Notice of Application
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and
requests for hearings on applications to import narcotic raw material
are not appropriate.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act [(21 U.S.C. 952 (a)(2)(B)] may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR Sec. 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 13, 2010.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substances in schedule I or II are, and will continue to be, required
to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the
requirements for such registration pursuant to 21 U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-28519 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P